Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioProcessOL
bioprocessonline.com > doc > let-the-tech-transfer-work-for-you-strategic-approaches-on-the-path-to-gmp-manufacture-0001

Let The Tech Transfer Work For You: Strategic Approaches On The Path To GMP Manufacture

18+ hour, 16+ min ago   (198+ words) Let The Tech Transfer Work For You Strategic Approaches On The Path To GMP Manufacture Bioprocess Online Let The Tech Transfer Work For You: Strategic Approaches On The Path To GMP Manufacture Tech transfer is often treated as a handoff,…...

BioProcessOL
bioprocessonline.com > doc > from-research-to-reality-designing-scalable-cell-therapy-for-successful-development-0001

From Research To Reality: Designing Scalable Cell Therapy For Successful Development

2+ day, 16+ hour ago   (170+ words) Bioprocess Online Presentation | July 23, 2026 From Research To Reality: Designing Scalable Cell Therapy For Successful Development Only 49 cell and gene therapies have reached commercial approval despite more than 5,000 active clinical trials. The gap is largely operational: biological variability, process inconsistency, and…...

BioProcessOL
bioprocessonline.com > doc > multispecific-manufacturability-starts-with-molecular-design-0001

Multispecific Manufacturability Starts With Molecular Design

4+ day, 23+ hour ago   (472+ words) From The Editor | July 21, 2026 By Tyler Menichiello, Chief Editor, Bioprocess Online When I think about drug development — and more specifically, the people at small- to mid-size biotech companies working to bring these products to market — I picture Sisyphus rolling these…...

Google News
bioprocessonline.com > doc > rezon-bio-appoints-dr-hubert-scholze-as-chief-business-officer-to-accelerate-global-commercial-expansion-0001

Rezon Bio Appoints Dr Hubert Scholze As Chief Business Officer To Accelerate Global Commercial Expansion

5+ day, 23+ hour ago   (479+ words) Bioprocess Online News | July 20, 2026 Rezon Bio Appoints Dr. Hubert Scholze As Chief Business Officer To Accelerate Global Commercial Expansion Duchnice-Warsaw, Poland – Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), today announced the appointment of Dr. Hubert…...

BioProcessOL
bioprocessonline.com > doc > native-rplc-for-adcs-how-column-hydrophobicity-shapes-dar-separation-0001

Native RPLC For ADCs: How Column Hydrophobicity Shapes DAR Separation

1+ week, 2+ day ago   (159+ words) Bioprocess Online Native RPLC For ADCs: How Column Hydrophobicity Shapes DAR Separation This content is brought to you by Phenomenex, a Danaher Operating Company. ADC characterization can quickly become a bottleneck when intact mass analysis has to account for multiple…...

BioProcessOL
bioprocessonline.com > doc > peptide-mapping-of-adeno-associated-virus-capsid-proteins-0001

Peptide Mapping Of Adeno Associated Virus Capsid Proteins

1+ week, 2+ day ago   (155+ words) Bioprocess Online Peptide Mapping Of Adeno Associated Virus Capsid Proteins By Lorne Nelson, Mastooreh Chamanian, PhD, Roxana Eggleston-Rangel, and Bryan Tackett, PhD This content is brought to you by Phenomenex, a Danaher Operating Company. AAV-based gene therapies depend on capsid…...

BioProcessOL
bioprocessonline.com > doc > characterization-of-antibody-drug-conjugates-using-d-lc-and-native-ms-0001

Characterization Of Antibody‑Drug Conjugates Using 2D-LC And Native MS

1+ week, 6+ day ago   (152+ words) Bioprocess Online Characterization Of Antibody‑Drug Conjugates Using 2D-LC And Native MS By David L. Wong and Sarah M. Stow Antibody drug conjugates (ADCs) continue to gain traction as targeted biotherapeutics, but maintaining control over drug-to-antibody ratio (DAR) remains essential…...

BioProcessOL
bioprocessonline.com > doc > bio-modernizing-the-fda-and-bolstering-the-workforce-0001

BIO 2026: Modernizing The FDA And Bolstering The Workforce

2+ week, 2+ day ago   (954+ words) From The Editor | July 10, 2026 By Tyler Menichiello, Chief Editor, Bioprocess Online This year marks 50 years since the world’s first biotech was established (Genentech, 1976), so much of the conversation centered around defining the next 50 years of innovation, which included sessions around…...

BioProcessOL
bioprocessonline.com > doc > bio-crowley-on-competing-with-china-and-modernizing-the-fda-0001

BIO 2026: Crowley On Competing With China And Modernizing The FDA

2+ week, 4+ day ago   (499+ words) From The Editor | July 8, 2026 By Tyler Menichiello, Chief Editor, Bioprocess Online “Biotechnology is a national security imperative,” Crowley stressed in his response to a question about the Biosecure Act and competition with China. “We believe that the world is a…...

BioProcessOL
bioprocessonline.com > doc > an-open-source-modeling-tool-for-suspended-continuous-lyophilization-0001

An Open-Source Modeling Tool For Suspended Continuous Lyophilization

2+ week, 5+ day ago   (463+ words) Guest Column | July 7, 2026 A conversation between Prakitr Srisuma and Life Science Connect's Jon O'Connell A new twist on a well-established method, continuous lyophilization approaches are attracting attention because they can improve equipment use, support automation, and reduce the interruptions that…...